| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d3becb69b903bae0883b4942765bb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251dbe11c5b1f7b3ab6d6787fe7c57dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b5d123f8690cba751131e8cbb32df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda6edd6722402822594cdd11b5d4d77 |
| publicationDate |
2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1863481-A1 |
| titleOfInvention |
Methods for administering ixabepilone |
| abstract |
Methods for administering ixabepilone to patients are provided, wherein ixabepilone has the formula (I). One aspect of the invention comprises the use of a Y-site or dual source administration technique that provides enhanced ixabepilone stability and allows for greater flexibility in infusion time and/or product preparation. |
| priorityDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |